Clinical Trial

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

Study acronym: CAPAZ-2D
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 8, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-09; most recent amendment 2026-01-07.
Status change: Not Yet Recruiting → Recruiting 2025-10-07
Trial Details
NCT Number NCT07065721
Lead Sponsor San Diego State University
Collaborators: Scripps Health
Conditions Type 2 Diabetes Mellitus (T2DM)
Enrollment 40 participants
Start Date 2025-10-02
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-08